nodes	percent_of_prediction	percent_of_DWPC	metapath
Flavoxate—PDE4D—asthma	0.126	0.367	CbGaD
Flavoxate—PDE4A—asthma	0.119	0.346	CbGaD
Flavoxate—PDE4B—asthma	0.0985	0.287	CbGaD
Flavoxate—PDE8A—Ketotifen—asthma	0.0564	0.109	CbGbCtD
Flavoxate—PDE8B—Ketotifen—asthma	0.0564	0.109	CbGbCtD
Flavoxate—PDE7A—Dyphylline—asthma	0.0467	0.09	CbGbCtD
Flavoxate—PDE7B—Dyphylline—asthma	0.0467	0.09	CbGbCtD
Flavoxate—PDE7B—Ketotifen—asthma	0.0448	0.0862	CbGbCtD
Flavoxate—PDE7A—Ketotifen—asthma	0.0448	0.0862	CbGbCtD
Flavoxate—PDE4C—Dyphylline—asthma	0.0224	0.0432	CbGbCtD
Flavoxate—PDE4C—Ketotifen—asthma	0.0215	0.0414	CbGbCtD
Flavoxate—PDE4D—Dyphylline—asthma	0.0208	0.04	CbGbCtD
Flavoxate—PDE4D—Ketotifen—asthma	0.0199	0.0384	CbGbCtD
Flavoxate—PDE4C—Theophylline—asthma	0.016	0.0308	CbGbCtD
Flavoxate—PDE4A—Dyphylline—asthma	0.0154	0.0297	CbGbCtD
Flavoxate—PDE4D—Theophylline—asthma	0.0148	0.0285	CbGbCtD
Flavoxate—PDE4A—Ketotifen—asthma	0.0148	0.0285	CbGbCtD
Flavoxate—PDE4B—Dyphylline—asthma	0.0147	0.0283	CbGbCtD
Flavoxate—PDE4B—Ketotifen—asthma	0.0141	0.0271	CbGbCtD
Flavoxate—PDE4A—Aminophylline—asthma	0.0117	0.0225	CbGbCtD
Flavoxate—PDE4A—Theophylline—asthma	0.011	0.0211	CbGbCtD
Flavoxate—PDE4B—Theophylline—asthma	0.0105	0.0201	CbGbCtD
Flavoxate—CHRM1—Ipratropium bromide—asthma	0.00469	0.00904	CbGbCtD
Flavoxate—CHRM2—Ipratropium bromide—asthma	0.00433	0.00833	CbGbCtD
Flavoxate—CHRM1—Tiotropium—asthma	0.00356	0.00685	CbGbCtD
Flavoxate—CHRM2—Tiotropium—asthma	0.00328	0.00632	CbGbCtD
Flavoxate—PDE8B—bronchus—asthma	0.000957	0.07	CbGeAlD
Flavoxate—PDE7B—adrenal gland—asthma	0.000885	0.0648	CbGeAlD
Flavoxate—PDE8A—adrenal cortex—asthma	0.000878	0.0643	CbGeAlD
Flavoxate—PDE8A—bronchus—asthma	0.000861	0.063	CbGeAlD
Flavoxate—PDE8A—smooth muscle tissue—asthma	0.000843	0.0616	CbGeAlD
Flavoxate—PDE7B—lung—asthma	0.000776	0.0568	CbGeAlD
Flavoxate—PDE8A—trachea—asthma	0.000773	0.0566	CbGeAlD
Flavoxate—PDE8B—adrenal gland—asthma	0.000705	0.0516	CbGeAlD
Flavoxate—PDE8A—adrenal gland—asthma	0.000634	0.0464	CbGeAlD
Flavoxate—PDE8B—lung—asthma	0.000618	0.0452	CbGeAlD
Flavoxate—Raloxifene—ESR2—asthma	0.000604	0.668	CrCbGaD
Flavoxate—PDE4D—adrenal gland—asthma	0.000574	0.042	CbGeAlD
Flavoxate—PDE8A—lung—asthma	0.000556	0.0407	CbGeAlD
Flavoxate—PDE4A—adrenal gland—asthma	0.000508	0.0372	CbGeAlD
Flavoxate—PDE4D—lung—asthma	0.000504	0.0368	CbGeAlD
Flavoxate—PDE4B—respiratory system—asthma	0.0005	0.0366	CbGeAlD
Flavoxate—PDE4A—lung—asthma	0.000446	0.0326	CbGeAlD
Flavoxate—PDE4B—bronchus—asthma	0.000412	0.0301	CbGeAlD
Flavoxate—CHRM2—cardiovascular system—asthma	0.000381	0.0278	CbGeAlD
Flavoxate—PDE4B—trachea—asthma	0.00037	0.0271	CbGeAlD
Flavoxate—CHRM1—cardiovascular system—asthma	0.000346	0.0253	CbGeAlD
Flavoxate—CHRM1—trachea—asthma	0.000334	0.0245	CbGeAlD
Flavoxate—PDE4B—adrenal gland—asthma	0.000303	0.0222	CbGeAlD
Flavoxate—Antrafenine—PTGS2—asthma	0.0003	0.332	CrCbGaD
Flavoxate—PDE4B—lung—asthma	0.000266	0.0194	CbGeAlD
Flavoxate—Vomiting—Dyphylline—asthma	0.000264	0.00461	CcSEcCtD
Flavoxate—Feeling abnormal—Zileuton—asthma	0.000263	0.0046	CcSEcCtD
Flavoxate—Urticaria—Ketotifen—asthma	0.000262	0.00458	CcSEcCtD
Flavoxate—Headache—Dyphylline—asthma	0.00026	0.00454	CcSEcCtD
Flavoxate—Dry mouth—Ciclesonide—asthma	0.000255	0.00445	CcSEcCtD
Flavoxate—Tachycardia—Theophylline—asthma	0.000255	0.00445	CcSEcCtD
Flavoxate—Urticaria—Zileuton—asthma	0.000253	0.00443	CcSEcCtD
Flavoxate—Headache—Isoprenaline—asthma	0.000252	0.00442	CcSEcCtD
Flavoxate—Feeling abnormal—Pirbuterol—asthma	0.00025	0.00437	CcSEcCtD
Flavoxate—Vertigo—Cromoglicic acid—asthma	0.00025	0.00437	CcSEcCtD
Flavoxate—Tension—Ipratropium bromide—asthma	0.000249	0.00436	CcSEcCtD
Flavoxate—Urticaria—Orciprenaline—asthma	0.000248	0.00433	CcSEcCtD
Flavoxate—Eosinophilia—Montelukast—asthma	0.000247	0.00431	CcSEcCtD
Flavoxate—Nervousness—Ipratropium bromide—asthma	0.000247	0.00431	CcSEcCtD
Flavoxate—Vomiting—Terbutaline—asthma	0.000246	0.00431	CcSEcCtD
Flavoxate—Nausea—Dyphylline—asthma	0.000246	0.00431	CcSEcCtD
Flavoxate—Palpitations—Cromoglicic acid—asthma	0.000246	0.0043	CcSEcCtD
Flavoxate—Headache—Terbutaline—asthma	0.000243	0.00424	CcSEcCtD
Flavoxate—Urticaria—Nedocromil—asthma	0.000243	0.00424	CcSEcCtD
Flavoxate—Tension—Salmeterol—asthma	0.00024	0.00421	CcSEcCtD
Flavoxate—CHRM1—lung—asthma	0.00024	0.0176	CbGeAlD
Flavoxate—Nausea—Isoprenaline—asthma	0.000239	0.00419	CcSEcCtD
Flavoxate—Vision blurred—Ipratropium bromide—asthma	0.000239	0.00418	CcSEcCtD
Flavoxate—Nervousness—Salmeterol—asthma	0.000238	0.00416	CcSEcCtD
Flavoxate—Urticaria—Fluticasone furoate—asthma	0.000232	0.00405	CcSEcCtD
Flavoxate—Vision blurred—Fluticasone Propionate—asthma	0.000232	0.00405	CcSEcCtD
Flavoxate—Nausea—Terbutaline—asthma	0.00023	0.00402	CcSEcCtD
Flavoxate—Tension—Aminophylline—asthma	0.000228	0.004	CcSEcCtD
Flavoxate—Nervousness—Aminophylline—asthma	0.000226	0.00395	CcSEcCtD
Flavoxate—Feeling abnormal—Zafirlukast—asthma	0.000226	0.00395	CcSEcCtD
Flavoxate—Palpitations—Ipratropium bromide—asthma	0.000224	0.00392	CcSEcCtD
Flavoxate—Drowsiness—Montelukast—asthma	0.000222	0.00388	CcSEcCtD
Flavoxate—Tachycardia—Cromoglicic acid—asthma	0.000221	0.00387	CcSEcCtD
Flavoxate—Urticaria—Zafirlukast—asthma	0.000218	0.00381	CcSEcCtD
Flavoxate—Palpitations—Fluticasone Propionate—asthma	0.000217	0.0038	CcSEcCtD
Flavoxate—Palpitations—Salmeterol—asthma	0.000217	0.00379	CcSEcCtD
Flavoxate—Tension—Loratadine—asthma	0.000216	0.00377	CcSEcCtD
Flavoxate—Drowsiness—Salbutamol—asthma	0.000214	0.00374	CcSEcCtD
Flavoxate—Nervousness—Loratadine—asthma	0.000214	0.00374	CcSEcCtD
Flavoxate—Dry mouth—Ipratropium bromide—asthma	0.000211	0.0037	CcSEcCtD
Flavoxate—Vomiting—Ketotifen—asthma	0.000209	0.00366	CcSEcCtD
Flavoxate—Urticaria—Theophylline—asthma	0.000207	0.00362	CcSEcCtD
Flavoxate—Urticaria—Beclomethasone—asthma	0.000207	0.00362	CcSEcCtD
Flavoxate—Vision blurred—Tiotropium—asthma	0.000207	0.00362	CcSEcCtD
Flavoxate—Headache—Ketotifen—asthma	0.000206	0.00361	CcSEcCtD
Flavoxate—Palpitations—Aminophylline—asthma	0.000206	0.0036	CcSEcCtD
Flavoxate—Dry mouth—Fluticasone Propionate—asthma	0.000205	0.00358	CcSEcCtD
Flavoxate—Dry mouth—Salmeterol—asthma	0.000204	0.00357	CcSEcCtD
Flavoxate—Vomiting—Zileuton—asthma	0.000203	0.00355	CcSEcCtD
Flavoxate—Tachycardia—Ipratropium bromide—asthma	0.000202	0.00354	CcSEcCtD
Flavoxate—Somnolence—Cromoglicic acid—asthma	0.000202	0.00353	CcSEcCtD
Flavoxate—Skin disorder—Ipratropium bromide—asthma	0.000201	0.00352	CcSEcCtD
Flavoxate—Headache—Zileuton—asthma	0.0002	0.0035	CcSEcCtD
Flavoxate—Vomiting—Orciprenaline—asthma	0.000198	0.00347	CcSEcCtD
Flavoxate—Urticaria—Ciclesonide—asthma	0.000198	0.00347	CcSEcCtD
Flavoxate—Headache—Indacaterol—asthma	0.000197	0.00344	CcSEcCtD
Flavoxate—Tachycardia—Fluticasone Propionate—asthma	0.000196	0.00342	CcSEcCtD
Flavoxate—Nausea—Ketotifen—asthma	0.000196	0.00342	CcSEcCtD
Flavoxate—Headache—Orciprenaline—asthma	0.000195	0.00342	CcSEcCtD
Flavoxate—Tachycardia—Salmeterol—asthma	0.000195	0.00341	CcSEcCtD
Flavoxate—Skin disorder—Fluticasone Propionate—asthma	0.000195	0.00341	CcSEcCtD
Flavoxate—Palpitations—Loratadine—asthma	0.000194	0.0034	CcSEcCtD
Flavoxate—Skin disorder—Salmeterol—asthma	0.000194	0.0034	CcSEcCtD
Flavoxate—Vomiting—Nedocromil—asthma	0.000194	0.0034	CcSEcCtD
Flavoxate—Palpitations—Tiotropium—asthma	0.000194	0.00339	CcSEcCtD
Flavoxate—Vomiting—Pirbuterol—asthma	0.000193	0.00337	CcSEcCtD
Flavoxate—Vision blurred—Flunisolide—asthma	0.000192	0.00335	CcSEcCtD
Flavoxate—Headache—Nedocromil—asthma	0.000191	0.00335	CcSEcCtD
Flavoxate—Headache—Pirbuterol—asthma	0.00019	0.00332	CcSEcCtD
Flavoxate—Nausea—Zileuton—asthma	0.000189	0.00331	CcSEcCtD
Flavoxate—Feeling abnormal—Cromoglicic acid—asthma	0.000187	0.00327	CcSEcCtD
Flavoxate—Nausea—Indacaterol—asthma	0.000187	0.00326	CcSEcCtD
Flavoxate—Tachycardia—Aminophylline—asthma	0.000185	0.00324	CcSEcCtD
Flavoxate—Nausea—Orciprenaline—asthma	0.000185	0.00324	CcSEcCtD
Flavoxate—Somnolence—Ipratropium bromide—asthma	0.000184	0.00322	CcSEcCtD
Flavoxate—Dry mouth—Loratadine—asthma	0.000183	0.0032	CcSEcCtD
Flavoxate—Vertigo—Flunisolide—asthma	0.000183	0.0032	CcSEcCtD
Flavoxate—Headache—Fluticasone furoate—asthma	0.000183	0.0032	CcSEcCtD
Flavoxate—Dry mouth—Tiotropium—asthma	0.000183	0.0032	CcSEcCtD
Flavoxate—Nausea—Nedocromil—asthma	0.000181	0.00317	CcSEcCtD
Flavoxate—Urticaria—Cromoglicic acid—asthma	0.00018	0.00315	CcSEcCtD
Flavoxate—Nausea—Pirbuterol—asthma	0.00018	0.00315	CcSEcCtD
Flavoxate—Palpitations—Flunisolide—asthma	0.00018	0.00314	CcSEcCtD
Flavoxate—Tachycardia—Loratadine—asthma	0.000175	0.00306	CcSEcCtD
Flavoxate—Tachycardia—Tiotropium—asthma	0.000175	0.00306	CcSEcCtD
Flavoxate—Skin disorder—Loratadine—asthma	0.000174	0.00305	CcSEcCtD
Flavoxate—Vomiting—Zafirlukast—asthma	0.000174	0.00305	CcSEcCtD
Flavoxate—Skin disorder—Tiotropium—asthma	0.000174	0.00304	CcSEcCtD
Flavoxate—Tension—Arformoterol—asthma	0.000174	0.00304	CcSEcCtD
Flavoxate—Tension—Formoterol—asthma	0.000174	0.00304	CcSEcCtD
Flavoxate—Nausea—Fluticasone furoate—asthma	0.000173	0.00303	CcSEcCtD
Flavoxate—Nervousness—Arformoterol—asthma	0.000172	0.00301	CcSEcCtD
Flavoxate—Nervousness—Formoterol—asthma	0.000172	0.00301	CcSEcCtD
Flavoxate—Headache—Zafirlukast—asthma	0.000172	0.003	CcSEcCtD
Flavoxate—Vomiting—Theophylline—asthma	0.000166	0.0029	CcSEcCtD
Flavoxate—Feeling abnormal—Fluticasone Propionate—asthma	0.000165	0.00289	CcSEcCtD
Flavoxate—Feeling abnormal—Salmeterol—asthma	0.000165	0.00288	CcSEcCtD
Flavoxate—Urticaria—Ipratropium bromide—asthma	0.000165	0.00288	CcSEcCtD
Flavoxate—Tension—Salbutamol—asthma	0.000164	0.00287	CcSEcCtD
Flavoxate—Headache—Theophylline—asthma	0.000163	0.00286	CcSEcCtD
Flavoxate—Headache—Beclomethasone—asthma	0.000163	0.00286	CcSEcCtD
Flavoxate—Nausea—Zafirlukast—asthma	0.000163	0.00285	CcSEcCtD
Flavoxate—Nervousness—Salbutamol—asthma	0.000162	0.00284	CcSEcCtD
Flavoxate—Tachycardia—Flunisolide—asthma	0.000162	0.00283	CcSEcCtD
Flavoxate—Somnolence—Loratadine—asthma	0.00016	0.00279	CcSEcCtD
Flavoxate—Urticaria—Fluticasone Propionate—asthma	0.000159	0.00279	CcSEcCtD
Flavoxate—Tension—Budesonide—asthma	0.000159	0.00278	CcSEcCtD
Flavoxate—Urticaria—Salmeterol—asthma	0.000159	0.00278	CcSEcCtD
Flavoxate—Nervousness—Budesonide—asthma	0.000157	0.00275	CcSEcCtD
Flavoxate—Dry mouth—Mometasone—asthma	0.000157	0.00275	CcSEcCtD
Flavoxate—Palpitations—Arformoterol—asthma	0.000157	0.00274	CcSEcCtD
Flavoxate—Palpitations—Formoterol—asthma	0.000157	0.00274	CcSEcCtD
Flavoxate—Headache—Ciclesonide—asthma	0.000156	0.00274	CcSEcCtD
Flavoxate—Nausea—Beclomethasone—asthma	0.000155	0.00271	CcSEcCtD
Flavoxate—Nausea—Theophylline—asthma	0.000155	0.00271	CcSEcCtD
Flavoxate—Palpitations—Montelukast—asthma	0.000153	0.00268	CcSEcCtD
Flavoxate—Vision blurred—Budesonide—asthma	0.000153	0.00267	CcSEcCtD
Flavoxate—Urticaria—Aminophylline—asthma	0.000151	0.00264	CcSEcCtD
Flavoxate—Vertigo—Salbutamol—asthma	0.00015	0.00263	CcSEcCtD
Flavoxate—Nausea—Ciclesonide—asthma	0.000148	0.00259	CcSEcCtD
Flavoxate—Feeling abnormal—Loratadine—asthma	0.000148	0.00259	CcSEcCtD
Flavoxate—Palpitations—Salbutamol—asthma	0.000148	0.00259	CcSEcCtD
Flavoxate—Dry mouth—Arformoterol—asthma	0.000147	0.00258	CcSEcCtD
Flavoxate—Dry mouth—Formoterol—asthma	0.000147	0.00258	CcSEcCtD
Flavoxate—Vertigo—Budesonide—asthma	0.000146	0.00255	CcSEcCtD
Flavoxate—Palpitations—Budesonide—asthma	0.000143	0.0025	CcSEcCtD
Flavoxate—Urticaria—Tiotropium—asthma	0.000142	0.00249	CcSEcCtD
Flavoxate—Headache—Cromoglicic acid—asthma	0.000142	0.00249	CcSEcCtD
Flavoxate—Tachycardia—Arformoterol—asthma	0.000141	0.00247	CcSEcCtD
Flavoxate—Tachycardia—Formoterol—asthma	0.000141	0.00247	CcSEcCtD
Flavoxate—Skin disorder—Arformoterol—asthma	0.00014	0.00246	CcSEcCtD
Flavoxate—Skin disorder—Formoterol—asthma	0.00014	0.00246	CcSEcCtD
Flavoxate—Dry mouth—Salbutamol—asthma	0.000139	0.00244	CcSEcCtD
Flavoxate—Skin disorder—Montelukast—asthma	0.000138	0.00241	CcSEcCtD
Flavoxate—Feeling abnormal—Flunisolide—asthma	0.000137	0.00239	CcSEcCtD
Flavoxate—Dry mouth—Budesonide—asthma	0.000135	0.00236	CcSEcCtD
Flavoxate—Nausea—Cromoglicic acid—asthma	0.000135	0.00236	CcSEcCtD
Flavoxate—Confusional state—Budesonide—asthma	0.000133	0.00233	CcSEcCtD
Flavoxate—Tachycardia—Salbutamol—asthma	0.000133	0.00233	CcSEcCtD
Flavoxate—Skin disorder—Salbutamol—asthma	0.000133	0.00232	CcSEcCtD
Flavoxate—Urticaria—Flunisolide—asthma	0.000132	0.00231	CcSEcCtD
Flavoxate—Vomiting—Ipratropium bromide—asthma	0.000132	0.0023	CcSEcCtD
Flavoxate—Headache—Ipratropium bromide—asthma	0.00013	0.00227	CcSEcCtD
Flavoxate—Tachycardia—Budesonide—asthma	0.000129	0.00226	CcSEcCtD
Flavoxate—Somnolence—Formoterol—asthma	0.000129	0.00225	CcSEcCtD
Flavoxate—Somnolence—Arformoterol—asthma	0.000129	0.00225	CcSEcCtD
Flavoxate—Skin disorder—Budesonide—asthma	0.000128	0.00225	CcSEcCtD
Flavoxate—Vomiting—Fluticasone Propionate—asthma	0.000127	0.00223	CcSEcCtD
Flavoxate—Vomiting—Salmeterol—asthma	0.000127	0.00222	CcSEcCtD
Flavoxate—Somnolence—Montelukast—asthma	0.000126	0.0022	CcSEcCtD
Flavoxate—Headache—Fluticasone Propionate—asthma	0.000126	0.0022	CcSEcCtD
Flavoxate—Headache—Salmeterol—asthma	0.000125	0.00219	CcSEcCtD
Flavoxate—Nausea—Ipratropium bromide—asthma	0.000123	0.00215	CcSEcCtD
Flavoxate—Somnolence—Salbutamol—asthma	0.000121	0.00212	CcSEcCtD
Flavoxate—Vomiting—Aminophylline—asthma	0.000121	0.00211	CcSEcCtD
Flavoxate—Feeling abnormal—Arformoterol—asthma	0.000119	0.00208	CcSEcCtD
Flavoxate—Feeling abnormal—Formoterol—asthma	0.000119	0.00208	CcSEcCtD
Flavoxate—Nausea—Fluticasone Propionate—asthma	0.000119	0.00208	CcSEcCtD
Flavoxate—Headache—Aminophylline—asthma	0.000119	0.00208	CcSEcCtD
Flavoxate—Nausea—Salmeterol—asthma	0.000119	0.00208	CcSEcCtD
Flavoxate—Somnolence—Budesonide—asthma	0.000118	0.00206	CcSEcCtD
Flavoxate—Urticaria—Formoterol—asthma	0.000115	0.00201	CcSEcCtD
Flavoxate—Urticaria—Arformoterol—asthma	0.000115	0.00201	CcSEcCtD
Flavoxate—Vomiting—Loratadine—asthma	0.000114	0.002	CcSEcCtD
Flavoxate—Vomiting—Tiotropium—asthma	0.000114	0.00199	CcSEcCtD
Flavoxate—Nausea—Aminophylline—asthma	0.000113	0.00197	CcSEcCtD
Flavoxate—Urticaria—Montelukast—asthma	0.000112	0.00197	CcSEcCtD
Flavoxate—Feeling abnormal—Salbutamol—asthma	0.000112	0.00197	CcSEcCtD
Flavoxate—Headache—Loratadine—asthma	0.000112	0.00197	CcSEcCtD
Flavoxate—Headache—Tiotropium—asthma	0.000112	0.00196	CcSEcCtD
Flavoxate—Feeling abnormal—Budesonide—asthma	0.000109	0.00191	CcSEcCtD
Flavoxate—Urticaria—Salbutamol—asthma	0.000108	0.0019	CcSEcCtD
Flavoxate—Nausea—Loratadine—asthma	0.000107	0.00186	CcSEcCtD
Flavoxate—Nausea—Tiotropium—asthma	0.000106	0.00186	CcSEcCtD
Flavoxate—Vomiting—Flunisolide—asthma	0.000106	0.00185	CcSEcCtD
Flavoxate—Urticaria—Budesonide—asthma	0.000105	0.00184	CcSEcCtD
Flavoxate—Headache—Flunisolide—asthma	0.000104	0.00182	CcSEcCtD
Flavoxate—Nausea—Flunisolide—asthma	9.86e-05	0.00173	CcSEcCtD
Flavoxate—Vomiting—Mometasone—asthma	9.79e-05	0.00171	CcSEcCtD
Flavoxate—Headache—Mometasone—asthma	9.65e-05	0.00169	CcSEcCtD
Flavoxate—Vomiting—Arformoterol—asthma	9.19e-05	0.00161	CcSEcCtD
Flavoxate—Vomiting—Formoterol—asthma	9.19e-05	0.00161	CcSEcCtD
Flavoxate—Nausea—Mometasone—asthma	9.15e-05	0.0016	CcSEcCtD
Flavoxate—Headache—Arformoterol—asthma	9.06e-05	0.00158	CcSEcCtD
Flavoxate—Headache—Formoterol—asthma	9.06e-05	0.00158	CcSEcCtD
Flavoxate—Vision blurred—Prednisolone—asthma	9.04e-05	0.00158	CcSEcCtD
Flavoxate—Vomiting—Montelukast—asthma	9e-05	0.00157	CcSEcCtD
Flavoxate—Headache—Montelukast—asthma	8.87e-05	0.00155	CcSEcCtD
Flavoxate—Vomiting—Salbutamol—asthma	8.68e-05	0.00152	CcSEcCtD
Flavoxate—Vertigo—Prednisolone—asthma	8.62e-05	0.00151	CcSEcCtD
Flavoxate—Nausea—Arformoterol—asthma	8.59e-05	0.0015	CcSEcCtD
Flavoxate—Nausea—Formoterol—asthma	8.59e-05	0.0015	CcSEcCtD
Flavoxate—Headache—Salbutamol—asthma	8.55e-05	0.0015	CcSEcCtD
Flavoxate—Vertigo—Hydrocortisone—asthma	8.42e-05	0.00147	CcSEcCtD
Flavoxate—Nausea—Montelukast—asthma	8.41e-05	0.00147	CcSEcCtD
Flavoxate—Vomiting—Budesonide—asthma	8.41e-05	0.00147	CcSEcCtD
Flavoxate—Headache—Budesonide—asthma	8.28e-05	0.00145	CcSEcCtD
Flavoxate—Nausea—Salbutamol—asthma	8.11e-05	0.00142	CcSEcCtD
Flavoxate—Vertigo—Triamcinolone—asthma	7.93e-05	0.00139	CcSEcCtD
Flavoxate—Vertigo—Methylprednisolone—asthma	7.91e-05	0.00138	CcSEcCtD
Flavoxate—Nausea—Budesonide—asthma	7.85e-05	0.00137	CcSEcCtD
Flavoxate—Tachycardia—Prednisolone—asthma	7.64e-05	0.00134	CcSEcCtD
Flavoxate—Tachycardia—Hydrocortisone—asthma	7.46e-05	0.00131	CcSEcCtD
Flavoxate—Skin disorder—Hydrocortisone—asthma	7.43e-05	0.0013	CcSEcCtD
Flavoxate—Dry mouth—Triamcinolone—asthma	7.35e-05	0.00128	CcSEcCtD
Flavoxate—Confusional state—Methylprednisolone—asthma	7.24e-05	0.00127	CcSEcCtD
Flavoxate—Vertigo—Dexamethasone—asthma	7.19e-05	0.00126	CcSEcCtD
Flavoxate—Vertigo—Betamethasone—asthma	7.19e-05	0.00126	CcSEcCtD
Flavoxate—Tachycardia—Triamcinolone—asthma	7.03e-05	0.00123	CcSEcCtD
Flavoxate—Tachycardia—Methylprednisolone—asthma	7.01e-05	0.00123	CcSEcCtD
Flavoxate—Skin disorder—Methylprednisolone—asthma	6.98e-05	0.00122	CcSEcCtD
Flavoxate—Vision blurred—Prednisone—asthma	6.57e-05	0.00115	CcSEcCtD
Flavoxate—Feeling abnormal—Prednisolone—asthma	6.45e-05	0.00113	CcSEcCtD
Flavoxate—Tachycardia—Betamethasone—asthma	6.38e-05	0.00112	CcSEcCtD
Flavoxate—Tachycardia—Dexamethasone—asthma	6.38e-05	0.00112	CcSEcCtD
Flavoxate—Feeling abnormal—Hydrocortisone—asthma	6.3e-05	0.0011	CcSEcCtD
Flavoxate—Vertigo—Prednisone—asthma	6.26e-05	0.0011	CcSEcCtD
Flavoxate—Urticaria—Prednisolone—asthma	6.22e-05	0.00109	CcSEcCtD
Flavoxate—Urticaria—Hydrocortisone—asthma	6.07e-05	0.00106	CcSEcCtD
Flavoxate—Feeling abnormal—Triamcinolone—asthma	5.93e-05	0.00104	CcSEcCtD
Flavoxate—Feeling abnormal—Methylprednisolone—asthma	5.92e-05	0.00104	CcSEcCtD
Flavoxate—Urticaria—Triamcinolone—asthma	5.72e-05	0.001	CcSEcCtD
Flavoxate—Urticaria—Methylprednisolone—asthma	5.71e-05	0.000998	CcSEcCtD
Flavoxate—Tachycardia—Prednisone—asthma	5.55e-05	0.000971	CcSEcCtD
Flavoxate—Skin disorder—Prednisone—asthma	5.53e-05	0.000967	CcSEcCtD
Flavoxate—Feeling abnormal—Betamethasone—asthma	5.38e-05	0.000942	CcSEcCtD
Flavoxate—Feeling abnormal—Dexamethasone—asthma	5.38e-05	0.000942	CcSEcCtD
Flavoxate—Urticaria—Betamethasone—asthma	5.19e-05	0.000908	CcSEcCtD
Flavoxate—Urticaria—Dexamethasone—asthma	5.19e-05	0.000908	CcSEcCtD
Flavoxate—Headache—Prednisolone—asthma	4.9e-05	0.000858	CcSEcCtD
Flavoxate—Vomiting—Hydrocortisone—asthma	4.86e-05	0.00085	CcSEcCtD
Flavoxate—Headache—Hydrocortisone—asthma	4.79e-05	0.000838	CcSEcCtD
Flavoxate—Feeling abnormal—Prednisone—asthma	4.69e-05	0.00082	CcSEcCtD
Flavoxate—Nausea—Prednisolone—asthma	4.65e-05	0.000814	CcSEcCtD
Flavoxate—Vomiting—Triamcinolone—asthma	4.58e-05	0.000801	CcSEcCtD
Flavoxate—Vomiting—Methylprednisolone—asthma	4.57e-05	0.000799	CcSEcCtD
Flavoxate—Nausea—Hydrocortisone—asthma	4.54e-05	0.000795	CcSEcCtD
Flavoxate—Urticaria—Prednisone—asthma	4.52e-05	0.000791	CcSEcCtD
Flavoxate—Headache—Triamcinolone—asthma	4.51e-05	0.000789	CcSEcCtD
Flavoxate—Headache—Methylprednisolone—asthma	4.5e-05	0.000787	CcSEcCtD
Flavoxate—Nausea—Triamcinolone—asthma	4.28e-05	0.000748	CcSEcCtD
Flavoxate—Nausea—Methylprednisolone—asthma	4.27e-05	0.000746	CcSEcCtD
Flavoxate—Vomiting—Dexamethasone—asthma	4.15e-05	0.000727	CcSEcCtD
Flavoxate—Vomiting—Betamethasone—asthma	4.15e-05	0.000727	CcSEcCtD
Flavoxate—Headache—Betamethasone—asthma	4.09e-05	0.000716	CcSEcCtD
Flavoxate—Headache—Dexamethasone—asthma	4.09e-05	0.000716	CcSEcCtD
Flavoxate—Nausea—Dexamethasone—asthma	3.88e-05	0.000679	CcSEcCtD
Flavoxate—Nausea—Betamethasone—asthma	3.88e-05	0.000679	CcSEcCtD
Flavoxate—Vomiting—Prednisone—asthma	3.62e-05	0.000633	CcSEcCtD
Flavoxate—Headache—Prednisone—asthma	3.56e-05	0.000623	CcSEcCtD
Flavoxate—Nausea—Prednisone—asthma	3.38e-05	0.000591	CcSEcCtD
Flavoxate—CHRM2—Signaling Pathways—VIP—asthma	4.56e-06	6.94e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—UTS2—asthma	4.56e-06	6.94e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—C5AR1—asthma	4.56e-06	6.94e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CMA1—asthma	4.56e-06	6.94e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—ITPR1—asthma	4.55e-06	6.93e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—AGTR1—asthma	4.55e-06	6.92e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CXCL10—asthma	4.5e-06	6.85e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—ITPR1—asthma	4.49e-06	6.84e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—SERPINE1—asthma	4.47e-06	6.81e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—FN1—asthma	4.45e-06	6.78e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CXCL10—asthma	4.44e-06	6.77e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCR4—asthma	4.43e-06	6.74e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—ADRB2—asthma	4.37e-06	6.65e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCR4—asthma	4.37e-06	6.65e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—LEP—asthma	4.37e-06	6.65e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—STAT6—asthma	4.34e-06	6.61e-05	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—TGFB1—asthma	4.33e-06	6.59e-05	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—IL6—asthma	4.32e-06	6.58e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—ADRB2—asthma	4.31e-06	6.57e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—RHOA—asthma	4.31e-06	6.57e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—EDN1—asthma	4.3e-06	6.55e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—STAT6—asthma	4.28e-06	6.52e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—NOS3—asthma	4.27e-06	6.5e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CCL5—asthma	4.27e-06	6.5e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—POMC—asthma	4.26e-06	6.49e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL2RB—asthma	4.26e-06	6.49e-05	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—EGFR—asthma	4.25e-06	6.47e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—EDN1—asthma	4.24e-06	6.46e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PDE4D—asthma	4.22e-06	6.43e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CCL5—asthma	4.21e-06	6.41e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL2RB—asthma	4.21e-06	6.4e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CSF2—asthma	4.2e-06	6.4e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CCL2—asthma	4.17e-06	6.35e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PDE4D—asthma	4.17e-06	6.35e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IL6R—asthma	4.16e-06	6.33e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CSF2—asthma	4.15e-06	6.32e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—ITPR1—asthma	4.13e-06	6.29e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—FN1—asthma	4.12e-06	6.27e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—C5—asthma	4.11e-06	6.27e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PDE4B—asthma	4.11e-06	6.27e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TACR1—asthma	4.11e-06	6.27e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—CXCL8—asthma	4.11e-06	6.26e-05	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—asthma	4.1e-06	6.24e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—ITPR1—asthma	4.08e-06	6.21e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—EGFR—asthma	4.08e-06	6.21e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PDE4B—asthma	4.06e-06	6.18e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—C5—asthma	4.06e-06	6.18e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TACR1—asthma	4.06e-06	6.18e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—CXCL8—asthma	4.06e-06	6.18e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—POMC—asthma	4.06e-06	6.17e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CCL2—asthma	3.97e-06	6.04e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IL6R—asthma	3.96e-06	6.02e-05	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—IL6—asthma	3.94e-06	6e-05	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—IL6—asthma	3.94e-06	6e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—EDN1—asthma	3.9e-06	5.95e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—SERPINE1—asthma	3.89e-06	5.93e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—EGFR—asthma	3.88e-06	5.91e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CCL5—asthma	3.87e-06	5.9e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PLA2G4A—asthma	3.86e-06	5.88e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—EDN1—asthma	3.85e-06	5.87e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CCR5—asthma	3.84e-06	5.85e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CCL5—asthma	3.82e-06	5.82e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CSF2—asthma	3.82e-06	5.81e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PLA2G4A—asthma	3.81e-06	5.8e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CCR5—asthma	3.79e-06	5.78e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—IL2RA—asthma	3.79e-06	5.77e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CXCL8—asthma	3.79e-06	5.76e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CSF2—asthma	3.77e-06	5.74e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCR3—asthma	3.76e-06	5.73e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—C3—asthma	3.76e-06	5.72e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—RHOA—asthma	3.75e-06	5.72e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—POMC—asthma	3.75e-06	5.71e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—IL2RA—asthma	3.74e-06	5.69e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—NOS3—asthma	3.72e-06	5.66e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCR3—asthma	3.72e-06	5.66e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—C3—asthma	3.71e-06	5.65e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—SERPINE1—asthma	3.7e-06	5.64e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CCL2—asthma	3.67e-06	5.59e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NPY—asthma	3.67e-06	5.58e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IL6R—asthma	3.66e-06	5.57e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NPY—asthma	3.62e-06	5.51e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IL2—asthma	3.62e-06	5.51e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—IL6—asthma	3.6e-06	5.48e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—EGFR—asthma	3.59e-06	5.47e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—RHOA—asthma	3.57e-06	5.44e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PPP2CA—asthma	3.55e-06	5.41e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AGTR2—asthma	3.54e-06	5.39e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—NOS3—asthma	3.54e-06	5.39e-05	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—IL6—asthma	3.51e-06	5.34e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PPP2CA—asthma	3.51e-06	5.34e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AGTR2—asthma	3.49e-06	5.32e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CCR5—asthma	3.49e-06	5.32e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CCR5—asthma	3.45e-06	5.25e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—IL2RA—asthma	3.44e-06	5.24e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—SERPINE1—asthma	3.43e-06	5.22e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MMP9—asthma	3.42e-06	5.21e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—C3—asthma	3.41e-06	5.19e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—PTEN—asthma	3.4e-06	5.18e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—IL2RA—asthma	3.4e-06	5.17e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—EDNRB—asthma	3.39e-06	5.16e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—C3—asthma	3.37e-06	5.13e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NPS—asthma	3.35e-06	5.11e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TAC1—asthma	3.35e-06	5.11e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—EDNRB—asthma	3.34e-06	5.09e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TAC1—asthma	3.31e-06	5.04e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NPS—asthma	3.31e-06	5.04e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—RHOA—asthma	3.31e-06	5.03e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CXCL8—asthma	3.3e-06	5.02e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CXCR3—asthma	3.29e-06	5.01e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NOS3—asthma	3.27e-06	4.98e-05	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—IL6—asthma	3.26e-06	4.97e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CXCR3—asthma	3.25e-06	4.94e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CYBA—asthma	3.19e-06	4.85e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IL2—asthma	3.15e-06	4.8e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CYBA—asthma	3.14e-06	4.79e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CXCL8—asthma	3.14e-06	4.78e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—IL6—asthma	3.13e-06	4.77e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PARP1—asthma	3.12e-06	4.75e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL5—asthma	3.12e-06	4.75e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PARP1—asthma	3.08e-06	4.69e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL5—asthma	3.08e-06	4.69e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—VEGFA—asthma	3.07e-06	4.68e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—STAT3—asthma	3.04e-06	4.64e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—BDKRB2—asthma	3.01e-06	4.58e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—POMC—asthma	3e-06	4.57e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IL2—asthma	3e-06	4.57e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—IL6—asthma	2.98e-06	4.54e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MMP9—asthma	2.98e-06	4.54e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—BDKRB2—asthma	2.97e-06	4.52e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—POMC—asthma	2.97e-06	4.52e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PTEN—asthma	2.96e-06	4.51e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ADCY2—asthma	2.91e-06	4.43e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CXCL8—asthma	2.9e-06	4.42e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL3—asthma	2.9e-06	4.42e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ADCY2—asthma	2.87e-06	4.38e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL3—asthma	2.86e-06	4.36e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MMP9—asthma	2.84e-06	4.32e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TGFB1—asthma	2.82e-06	4.3e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PTEN—asthma	2.82e-06	4.3e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IL2—asthma	2.77e-06	4.22e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—EGFR—asthma	2.77e-06	4.21e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—IL6—asthma	2.76e-06	4.2e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—KNG1—asthma	2.74e-06	4.17e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—POMC—asthma	2.73e-06	4.15e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AGTR1—asthma	2.72e-06	4.14e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—KNG1—asthma	2.7e-06	4.11e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—POMC—asthma	2.69e-06	4.1e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AGTR1—asthma	2.69e-06	4.09e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—VEGFA—asthma	2.68e-06	4.08e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CCL2—asthma	2.67e-06	4.06e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—IL6R—asthma	2.66e-06	4.05e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CXCL10—asthma	2.66e-06	4.05e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—STAT3—asthma	2.65e-06	4.04e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—RHOA—asthma	2.65e-06	4.03e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CCL2—asthma	2.63e-06	4.01e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—IL6R—asthma	2.63e-06	4e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MMP9—asthma	2.63e-06	4e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CXCL10—asthma	2.62e-06	4e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—RHOA—asthma	2.61e-06	3.98e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PTEN—asthma	2.61e-06	3.97e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NTRK1—asthma	2.61e-06	3.97e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ADRB2—asthma	2.58e-06	3.93e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NTRK1—asthma	2.58e-06	3.92e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ADRB2—asthma	2.55e-06	3.88e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—VEGFA—asthma	2.55e-06	3.88e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—STAT3—asthma	2.52e-06	3.84e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TGFB1—asthma	2.46e-06	3.74e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ITPR1—asthma	2.44e-06	3.72e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ITPR1—asthma	2.41e-06	3.67e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—EGFR—asthma	2.41e-06	3.67e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—RHOA—asthma	2.4e-06	3.66e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—RHOA—asthma	2.37e-06	3.61e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—VEGFA—asthma	2.36e-06	3.59e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TGFB1—asthma	2.34e-06	3.56e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—STAT3—asthma	2.33e-06	3.55e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CD86—asthma	2.33e-06	3.54e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CXCL8—asthma	2.32e-06	3.54e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—EDN1—asthma	2.31e-06	3.51e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CD86—asthma	2.3e-06	3.49e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CXCL8—asthma	2.29e-06	3.49e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—EGFR—asthma	2.29e-06	3.49e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCL5—asthma	2.29e-06	3.49e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PLA2G4A—asthma	2.28e-06	3.47e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—EDN1—asthma	2.28e-06	3.47e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCL5—asthma	2.26e-06	3.44e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CSF2—asthma	2.25e-06	3.43e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PLA2G4A—asthma	2.25e-06	3.43e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CSF2—asthma	2.23e-06	3.39e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—IL2—asthma	2.22e-06	3.38e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SMAD3—asthma	2.19e-06	3.34e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—IL2—asthma	2.19e-06	3.34e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SMAD3—asthma	2.17e-06	3.3e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TGFB1—asthma	2.16e-06	3.29e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IL6—asthma	2.13e-06	3.24e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—EGFR—asthma	2.12e-06	3.23e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CXCL8—asthma	2.11e-06	3.21e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PPP2CA—asthma	2.1e-06	3.2e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CXCL8—asthma	2.08e-06	3.17e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PPP2CA—asthma	2.07e-06	3.16e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCR5—asthma	2.06e-06	3.14e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCR5—asthma	2.04e-06	3.1e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL2RA—asthma	2.03e-06	3.09e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—IL2—asthma	2.02e-06	3.07e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—C3—asthma	2.02e-06	3.07e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL2RA—asthma	2.01e-06	3.05e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—IL2—asthma	1.99e-06	3.03e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—C3—asthma	1.99e-06	3.03e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PDGFB—asthma	1.96e-06	2.99e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PDGFB—asthma	1.94e-06	2.95e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—LEP—asthma	1.88e-06	2.86e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—LEP—asthma	1.85e-06	2.82e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IL6—asthma	1.85e-06	2.82e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—FN1—asthma	1.77e-06	2.69e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IL6—asthma	1.76e-06	2.68e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FN1—asthma	1.75e-06	2.66e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IL6—asthma	1.63e-06	2.48e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—POMC—asthma	1.61e-06	2.45e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—POMC—asthma	1.59e-06	2.42e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCL2—asthma	1.58e-06	2.4e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL6R—asthma	1.57e-06	2.39e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCL2—asthma	1.56e-06	2.37e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL6R—asthma	1.55e-06	2.36e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—EGFR—asthma	1.54e-06	2.35e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—EGFR—asthma	1.52e-06	2.32e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SERPINE1—asthma	1.47e-06	2.24e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SERPINE1—asthma	1.45e-06	2.21e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—RHOA—asthma	1.42e-06	2.16e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NOS3—asthma	1.41e-06	2.14e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—RHOA—asthma	1.4e-06	2.13e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NOS3—asthma	1.39e-06	2.11e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CXCL8—asthma	1.25e-06	1.9e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CXCL8—asthma	1.23e-06	1.87e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL2—asthma	1.19e-06	1.81e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—IL6—asthma	1.19e-06	1.81e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL2—asthma	1.18e-06	1.79e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—IL6—asthma	1.17e-06	1.78e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MMP9—asthma	1.13e-06	1.72e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PTEN—asthma	1.12e-06	1.71e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MMP9—asthma	1.11e-06	1.69e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PTEN—asthma	1.11e-06	1.68e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—VEGFA—asthma	1.01e-06	1.54e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—STAT3—asthma	1e-06	1.53e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—VEGFA—asthma	1e-06	1.52e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—STAT3—asthma	9.9e-07	1.51e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TGFB1—asthma	9.29e-07	1.42e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TGFB1—asthma	9.17e-07	1.4e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—EGFR—asthma	9.11e-07	1.39e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—EGFR—asthma	8.99e-07	1.37e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL6—asthma	7e-07	1.07e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL6—asthma	6.91e-07	1.05e-05	CbGpPWpGaD
